Clinical Trials
2
Active:0
Completed:0
Trial Phases
2 Phases
Phase 1:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (50.0%)Phase 1
1 (50.0%)Study of Intracerebroventricular Injections of Autologous Adipose-Derived Stem Cells (RB-ADSCs) in Participants With Mild-Moderate Alzheimer's Disease
Not Applicable
Not yet recruiting
- Conditions
- Alzheimer Disease
- Interventions
- Other: Placebo
- First Posted Date
- 2025-10-03
- Last Posted Date
- 2025-10-03
- Lead Sponsor
- Regeneration Biomedical, Inc.
- Target Recruit Count
- 115
- Registration Number
- NCT07205601
Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's Disease
- First Posted Date
- 2022-12-28
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- Regeneration Biomedical, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT05667649
- Locations
- 🇺🇸
Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
News
No news found